Cargando…
Is the Patient Infected with SARS-CoV-2?
The U.S. Food and Drug Administration currently uses the nasopharyngeal swab specimen as the reference standard for evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) assays. We propose that the patient-infected status algorithm is a superior way to classify whether an indivi...
Autores principales: | Klausner, Jeffrey D., Kojima, Noah, Butler-Wu, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092753/ https://www.ncbi.nlm.nih.gov/pubmed/33500362 http://dx.doi.org/10.1128/JCM.00147-21 |
Ejemplares similares
-
Protective immunity after recovery from SARS-CoV-2 infection
por: Kojima, Noah, et al.
Publicado: (2022) -
A national survey of early treatment seeking behavior among those with incident SARS-CoV-2 infection
por: Kojima, Noah, et al.
Publicado: (2022) -
Duration of SARS-CoV-2 viral culture positivity among different specimen types
por: Kojima, Noah, et al.
Publicado: (2021) -
Incidence of SARS-CoV-2 infection among previously infected or vaccinated employees
por: Kojima, N., et al.
Publicado: (2022) -
A Systematic Review of the Protective Effect of Prior
SARS-CoV-2 Infection on Repeat Infection
por: Kojima, N., et al.
Publicado: (2021)